The ROE as of December 2025 (TTM) for Artelo Biosciences, Inc. (ARTLW) is -496.36%

According to Artelo Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -496.36%. This represents a change of 597.27% compared to the average of -71.19% of the last 4 quarters.

Artelo Biosciences, Inc. (ARTLW) Historical ROE (quarterly & annually)

How has ARTLW ROE performed in the past?

The mean historical ROE of Artelo Biosciences, Inc. over the last ten years is 111.20%. The current -496.36% ROE has changed -546.37% with respect to the historical average. Over the past ten years (40 quarters), ARTLW's ROE was at its highest in in the May 2018 quarter at 632.61%. The ROE was at its lowest in in the March 2025 quarter at -363.80%.

Artelo Biosciences, Inc. (ARTLW) ROE by Quarter and Year

Discovering the peaks and valleys of Artelo Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Artelo Biosciences, Inc. (ARTLW) Average ROE

How has ARTLW ROE performed in the past?

The current ROE of Artelo Biosciences, Inc. (ARTLW) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Artelo Biosciences, Inc. (ARTLW) ROE vs. Peers

How is ARTLW’s ROE compared to its peers?

Artelo Biosciences, Inc.’s ROE is greater than Eyenovia, Inc. (-119.59%), greater than Arrowhead Pharmaceuticals, Inc. (-41.19%), less than Krystal Biotech, Inc. (19.36%), less than BioNTech SE (-1.83%), greater than Moderna, Inc. (-31.40%), less than Adynxx, Inc. (0%), greater than AVAX Technologies, Inc. (-70.38%), greater than BioCardia, Inc. (-344.15%), greater than Adial Pharmaceuticals, Inc. WT EXP 073123 (-58896.55%), greater than Ascletis Pharma Inc. (-197.71%), greater than Ampio Pharmaceuticals, Inc. (-13.49%), greater than NexImmune, Inc. (-113.96%), greater than CymaBay Therapeutics, Inc. (-180.64%), greater than Galera Therapeutics, Inc. (-64.17%), less than Exelixis, Inc. (9.10%), less than null (31.64%),

Build a custom stock screener for Artelo Biosciences, Inc. (ARTLW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artelo Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Artelo Biosciences, Inc. (ARTLW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Artelo Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.